U.S. Capital Markets Stock News

Limbach Holdings (LMB) is in focus after its Q1 2026 report showed sales of US$138.86 million, net income of US$4.38 million and reaffirmed full year revenue guidance of US$730 million to US$760 million. See our latest analysis for Limbach Holdings. The share price has pulled back sharply in the very short term, with a 7 day share price return of a 25.7% decline and a 1 year total shareholder return of a 38.19% decline, even after very large 3 and 5 year total shareholder gains. This suggests...

In the first quarter ended March 31, 2026, Jones Lang LaSalle reported higher sales of US$6,386.5 million and net income of US$159.0 million, while also completing a long-running US$1.70 billion share repurchase program and arranging major hotel sale and financing transactions in Florida. Together, the stronger quarterly results, sizable buybacks, and high-profile hospitality financing deals underline how JLL is leaning on fee-based advisory strength and capital allocation to reshape its...

In early May 2026, RH was caught in a broad sell-off affecting specialty retailers as rising oil, gasoline, and freight costs raised concerns about consumer discretionary spending and retailer margins ahead of the back-to-school season. The pressure on RH highlights how macroeconomic cost headwinds, rather than company-specific developments, can quickly reshape sentiment toward higher-end discretionary brands. We’ll now examine how this sector-wide cost pressure and consumer spending concern...

It's been a pretty great week for Evolent Health, Inc. ( NYSE:EVH ) shareholders, with its shares surging 14% to...

TransUnion ( NYSE:TRU ) announced strong profits, but the stock was stagnant. We did some digging, and we found some...

Alpha Teknova, Inc. ( NASDAQ:TKNO ) defied analyst predictions to release its quarterly results, which were ahead of...

It's been a good week for Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) shareholders, because the company has just...

Global markets are on edge, with inflation, interest rate expectations, energy prices, and geopolitics all competing for attention, yet many investors still want income that feels relatively steady. That is where high yield dividend fortresses come in: stocks offering 5%+ dividend yields and balance sheet strength that can help keep payouts at the center of your plan. Rather than chasing the hottest story, this screener focuses on resilience and cash returns. In this article, you will see...

EchoStar (SATS) is drawing fresh attention as investors increasingly treat the stock as a way to gain exposure to SpaceX, while its wireless and pay TV operations take a back seat in market discussions. See our latest analysis for EchoStar. The recent focus on EchoStar as a proxy for SpaceX appears to be a key driver behind its strong long term total shareholder returns. These returns are very large over one year and around 7x over three years, even as the latest 90 day share price return of...

Clearway Energy (CWEN) closed out FY 2025 with Q4 revenue of US$310 million and a basic EPS loss of US$0.85, set against trailing 12 month EPS of US$1.42 and net income of US$169 million that lifted the net margin to 11.8% from 6.4% a year earlier. Over recent quarters, the company has seen revenue move from US$298 million in Q1 2025 to a peak of US$429 million in Q3 2025, while quarterly EPS ranged from US$0.03 in Q1 to US$2.00 in Q3 before the Q4 loss. This leaves investors focused on how...

Solid Power (SLDP) is in focus after reporting first quarter 2026 results alongside progress on its electrolyte commercialization plans, giving you fresh numbers and project updates to weigh against the current share price. See our latest analysis for Solid Power. Solid Power’s recent earnings update, electrolyte progress with SK On and Samsung SDI, and funding raise come after a volatile period, with a 1-day share price return of negative 12.71% and a 1-year total shareholder return of very...

Solventum Corporation recently reported Q1 2026 results showing revenue of US$2,007 million versus US$2,070 million a year earlier, with net income falling to US$13 million and GAAP EPS easing, even as adjusted EPS of US$1.48 and organic sales growth of 2.1% surpassed analyst expectations. Management reaffirmed full-year 2026 guidance, highlighted progress on a US$500 million cost-savings program and major R&D and manufacturing expansions, and began executing a US$1 billion share repurchase...

Netskope (NasdaqGS:NTSK) has introduced AgentSkope, an AI-driven agentic operations platform for automating security and network workflows. The new platform brings a suite of AI-powered agents designed to handle routine and complex operational tasks for security and network teams. This launch adds a fresh product to Netskope's portfolio in automated cybersecurity operations, an area where many enterprises are seeking more efficiency. Netskope trades at $11.4, with the stock showing a 14.5%...

Caris Life Sciences (CAI) closed FY 2025 with Q4 revenue of US$292.9 million and basic EPS of US$0.29, alongside trailing 12 month revenue of US$812.0 million and a trailing basic EPS loss of US$3.22, set against a 97% year over year revenue increase and expectations for earnings to grow about 70.5% per year with profitability projected within three years. Over recent periods, the company has seen quarterly revenue move from US$101.6 million in Q3 2024 to US$129.9 million in Q4 2024, then to...

Stryker (NYSE:SYK) has completed its acquisition of Amplitude Vascular Systems, adding new peripheral vascular technology focused on arterial disease. A law firm has launched a securities investigation into Stryker related to the March cyberattack and its reported impact on financial results. These developments come as Stryker continues recent M&A activity, following its Inari Medical deal, while also facing fresh legal and regulatory scrutiny. Stryker enters these headlines with shares at...

News Corp (NWSA) has just reported Q2 2026 results, with revenue of US$2.4b and basic EPS of US$0.34, while trailing 12 month revenue stands at US$8.6b and EPS at US$0.78, supported by net income from ongoing operations of US$193 million in the quarter and US$439 million over the last year. The company has seen quarterly revenue range from US$2.1b to US$2.4b over the last six reported periods, with basic EPS moving between roughly US$0.09 and US$0.40. This gives investors a clear read on how...

In April 2026, IXT, a full MVNO specializing in secure IoT connectivity, announced it had integrated Zscaler’s Zero Trust Network Access into its SecureNet cellular platform at the SIM level, routing all device traffic through the Zscaler Zero Trust Exchange for inspection and policy enforcement. This move extends Zero Trust controls directly into global cellular infrastructure for high‑security, NIS2‑regulated industries, reducing reliance on VPNs and software agents for protecting widely...

Why Arch Capital Group (ACGL) is back in focus Arch Capital Group (ACGL) has drawn fresh attention after its first quarter 2026 results showed net income of US$1,047 million and higher earnings per share, alongside a completed share repurchase that reduced the share count. See our latest analysis for Arch Capital Group. Despite the strong first quarter update and completed buyback, the share price has slipped over the past three months, with a 90 day share price return showing a 6.37%...

In early May 2026, Freshpet reported first-quarter net sales of US$297.64 million, a swing to net income of US$48.51 million and higher full-year 2026 net sales growth guidance to 8%–11%. Beyond the headline numbers, the return to profitability alongside raised sales expectations suggests that Freshpet’s operational changes and brand investments are starting to translate into financial progress. With Freshpet now profitable and lifting its 2026 sales outlook, we’ll examine how this improved...

Why Exelon Stock Is Drawing Attention Now Exelon (EXC) has been on investors’ radar after recent share price moves, with the stock showing a 1-day return of 1.36% and a 9.46% decline over the past month. See our latest analysis for Exelon. Despite the recent 9.46% 1-month share price decline and a softer 7-day move, Exelon’s 1-year total shareholder return of 1.97% and 5-year total shareholder return of 65.72% suggest longer term holders have still seen positive results. This indicates...

In early May 2026, Himax Technologies reported first-quarter 2026 results showing revenue of US$199.01 million and net income of US$7.99 million, alongside guidance for sequential revenue and earnings growth in the second quarter. The company also declared an annual cash dividend of US$0.252 per ADS, equal to a 100% payout of last year's profit, underscoring management’s confidence in its balance sheet and cash generation while it ramps automotive, AI, and optical technologies. We’ll now...

Recent performance snapshot for Titan America Titan America (TTAM) has drawn attention after recent share price swings, with a 1 day decline of 1.53%, a month gain of 11.82%, and a 10.24% decline over the past 3 months. See our latest analysis for Titan America. Short term momentum around Titan America's US$16.75 share price has been choppy, but the 1 year total shareholder return of 22.55% points to stronger performance over a longer horizon. If Titan America's recent swings have you...

As you might know, Primoris Services Corporation ( NYSE:PRIM ) last week released its latest first-quarter, and things...

Corcept Therapeutics reported long term survival data from its DAZALS Phase 2 trial of dazucorilant in ALS. Patients receiving 300 mg daily experienced an 87% reduction in risk of death at two years. The trial did not meet its primary functional endpoint, but the survival benefit attracted attention at the ENCALS 2025 meeting. For investors tracking NasdaqCM:CORT, this new ALS data adds another layer to the story around Corcept Therapeutics beyond its core cortisol modulation work. The...